Transgenic commensals as mucosal protectants

Nat Biotechnol. 2000 Oct;18(10):1038-9. doi: 10.1038/80220.
No abstract available

Publication types

  • Comment
  • News

MeSH terms

  • Animals
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / immunology
  • Anti-Bacterial Agents / therapeutic use
  • Candidiasis / immunology
  • Candidiasis / microbiology
  • Candidiasis / therapy
  • Female
  • Humans
  • Immunization, Passive
  • Immunoglobulin Idiotypes / administration & dosage
  • Immunoglobulin Idiotypes / genetics
  • Immunoglobulin Idiotypes / immunology
  • Immunoglobulin Idiotypes / therapeutic use
  • Mucous Membrane / immunology*
  • Mucous Membrane / microbiology*
  • Mucous Membrane / virology
  • Mycotoxins / administration & dosage
  • Mycotoxins / chemistry
  • Mycotoxins / therapeutic use
  • Rats
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / immunology
  • Recombinant Proteins / therapeutic use
  • Sexually Transmitted Diseases / immunology
  • Sexually Transmitted Diseases / microbiology
  • Sexually Transmitted Diseases / therapy
  • Sexually Transmitted Diseases / virology
  • Streptococcus / genetics
  • Streptococcus / physiology*
  • Transgenes / genetics*
  • Vagina / cytology
  • Vagina / immunology
  • Vagina / microbiology

Substances

  • Anti-Bacterial Agents
  • Immunoglobulin Idiotypes
  • Mycotoxins
  • Recombinant Proteins